ASARFI HOSPITAL LIMITED

Healthcare · Healthcare Services

BSE: 543943
₹183.40
▼ -5.40 (-2.86%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
51/100
Moderate
Valuation
—/100
Data unavailable
Momentum
50/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹361 Cr
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
86.2
Free Cash Flow
₹0 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
1.45
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
4.86%
as of March 31, 2024
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
9.99%
as of March 31, 2024
Industry median 17.21% (61 companies)
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 3 met
  • No Quality score is Strong (70 or more)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 1 met
  • Yes 1-year return beats the industry median

Value and momentum

1 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.9%
Low 180.5000 · High 188.1500
1W return
8.2%
Low 163.0000 · High 192.5000
1M return
-14.7%
Low 163.0000 · High 215.0000
52W return
83.4%
Low 163.0000 · High 248.4000
Lifetime High ₹244.0000 (Aug. 18, 2026)
Lifetime Low ₹56.5700 (March 27, 2024)

Full price history and technicals →

EMA & SMA

Bullish5
Bearish1
5D
182.7
10D
181.9
20D
184.4
50D
169.1
100D
142.6
200D
105.9

Delivery and volume

Day avg. delivery
63.6%
Week avg. delivery
66.9%
Month avg. delivery
75.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

184.02
Pivot
First resistance187.53
Second resistance191.67
Third resistance195.18
First support179.88
Second support176.37
Third support172.23
Day RSI50.1
Day MFI44.2
Day MACD-0.96
Day MACD signal0.33

Beta

1M-0.87
3M-0.71
1Y-0.71
3Y0.59

Price change analysis

↓ -14.7%
Over 1 Month
LowHigh
163.00215.00
↑ 83.4%
Over 3 Months
LowHigh
163.00248.40
↑ 83.4%
Over 6 Months
LowHigh
163.00248.40
↑ 83.4%
Over 1 Year
LowHigh
163.00248.40
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (March 31, 2024)
₹44 Cr
Net profit (March 31, 2024)
₹2 Cr
Basic EPS (March 31, 2024)
₹0.6000

Ranks #37 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter61.17%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 61.17% in Jun 2026 qtr

Historical fii holding

All shareholding details →

DateClientDealActionQuantityPriceExchange
23 May 2025 HARISHKUMARGUPTA Bulk Sell 100,000 106.9900 BSE
9 May 2025 HARISHKUMARGUPTA Bulk Buy 100,000 106.9400 BSE
18 Mar 2025 NEW BERRY ADVISORS LTD Bulk Sell 100,000 79.3800 BSE
18 Mar 2025 ULTRA SIGMA PRIVATE LIMITED Bulk Buy 100,000 79.3800 BSE
15 Mar 2024 VALUE PROLIFIC CONSULTING SERVICES PVT LTD Bulk Sell 200,000 60.9600 BSE
15 Mar 2024 ANG CORPORATE SERVICES PVT LTD Bulk Buy 200,000 60.9600 BSE
7 Mar 2024 JINENDRA KUMAR JAIN Bulk Buy 116,000 72.1000 BSE
7 Mar 2024 NAMRATA CHANDRAPRAKASH KHANDELWAL Bulk Sell 119,000 72.0900 BSE
19 Jan 2024 NAMRATA CHANDRAPRAKASH KHANDELWAL Bulk Buy 140,000 96.0400 BSE
19 Jan 2024 VINEY EQUITY MARKET LLP Bulk Sell 155,000 96.0300 BSE

All bulk and block deals →

Corporate Announcements

All 2 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
5 Sep 2026 Company Update Asarfi Hospital Ltd - 543943 - Intimation Of Appointment Of Cost Auditor - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations. 2015.
5 Sep 2026 Others Asarfi Hospital Ltd - 543943 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Thin net profit margin (4.9%)

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about ASARFI HOSPITAL LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.